Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,476.76 million compared to CNY 1,498.95 million a year ago. Revenue was CNY 1,476.76 million compared to CNY 1,498.95 million a year ago.

Net income was CNY 233.02 million compared to CNY 292.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.5036 compared to CNY 0.7358 a year ago. Diluted earnings per share from continuing operations was CNY 0.5036 compared to CNY 0.7358 a year ago.